ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics
Headlines: Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most…
Automobili Lamborghini strengthens its Board of Management
New appointments to support the future strategy of the Sant’Agata Bolognese companySant’Agata…
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE…
Ragp Balcolu Appointed as Beko’s Chief Marketing and Strategy Officer
Ragıp BalcıoÄźlu, who previously served as Chief Commercial Officer of Beko in…
Beko Europe Appoints Akn Garzanl as New CEO
Akın Garzanlı, who previously served as CMO of Beko has been appointed…
openRxiv names Dr. Tracy Teal first CEO to advance open science
Scientist and nonprofit leader who previously led The Carpentries and Dryad to…
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.…
Shell completes sale of interest in Colonial Enterprises Inc. to Brookfield subsidiary
HOUSTON, July 31, 2025 /PRNewswire/ -- Shell Midstream Operating LLC (SMUS), a…